Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Patients with type 2 diabetes or obesity should consult a healthcare provider to determine if this treatment is appropriate
Nature 304 (5924), 368371
Elecoglipron is an oral small molecule GLP-1 RA (receptor agonist), Vanita Aroda, MD, director of Diabetes Clinical Research at Brigham and Womens Hospital, associate professor of medicine at Harvard Medical School, and lead author of this study, told Medical News Today
In the GLP-1 Drug Market, the Indication segment is primarily driven by Type 2 Diabetes, which holds the largest market share at 52% due to its high prevalence and increasing awareness of chronic disease management
US$ 20.19
US$ 26.69
US$ 26.90
US$ 26.37
US$ 23.32
US$ 22.30
